Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Tecan Group AG (TCHBF – Research Report), TransMedics Group (TMDX – Research Report) and Argenx Se (ARGX – Research Report).
Tecan Group AG (TCHBF)
In a report released today, Sebastian Vogel from UBS maintained a Buy rating on Tecan Group AG, with a price target of CHF425.00. The company’s shares closed last Tuesday at $381.00.
According to TipRanks.com, Vogel is ranked #4320 out of 8647 analysts.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Tecan Group AG with a $449.08 average price target, representing a 17.9% upside. In a report issued on January 3, Baader Bank also maintained a Buy rating on the stock with a CHF400.00 price target.
See Insiders’ Hot Stocks on TipRanks >>
TransMedics Group (TMDX)
In a report released today, Josh Jennings from TD Cowen reiterated a Buy rating on TransMedics Group. The company’s shares closed last Thursday at $75.08.
According to TipRanks.com, Jennings is a 4-star analyst with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for TransMedics Group with a $83.50 average price target.
Argenx Se (ARGX)
In a report released today, Xian Deng from UBS maintained a Hold rating on Argenx Se, with a price target of $410.00. The company’s shares closed last Thursday at $388.72.
Deng has an average return of
According to TipRanks.com, Deng is ranked #3083 out of 8647 analysts.
Currently, the analyst consensus on Argenx Se is a Strong Buy with an average price target of $482.32, implying a 26.5% upside from current levels. In a report issued on December 21, Scotiabank also maintained a Hold rating on the stock with a $346.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on TCHBF:
